Market Trends of Spain Ultrasound Devices Industry
High-intensity Focused Ultrasound Segment is Expected to Witness Significant Growth Over the Forecast Period
Focused ultrasonic energy is a non-invasive procedure for tissue ablation, and it can also be used to treat a variety of solid tumors. The high-intensity focused ultrasound (HIFU) is being utilized widely in healthcare practices to treat primary and metastatic tumors because it can accurately identify tumors for ablation. The high-intensity focused ultrasound devices segment is expected to witness significant growth as Spain has a high prevalence of cancer, and the applications of focused ultrasound are rising in this field for the treatment of various cancer types.
For instance, according to the data published by the Spanish Network of Cancer Registries in January 2021, an estimated 276.2 thousand new cases of cancer were recorded in Spain in 2021, out of which 43.6 thousand were colorectal cancer cases, 35.8 thousand were prostate cancer cases, and 33.4 thousand were breast cancer cases. Thus, the high prevalence of cancer in the country is expected to increase the usage of focused ultrasound devices for its treatment, thus driving the segment growth.
Moreover, according to a study published by Spanish authors in PubMed Central in February 2022, high-intensity focused ultrasound is said to be highly efficient in treating cancer such as pancreatic and prostate cancer. The source also stated that HIFU could be a safe and effective treatment for localized prostate cancer in patients of advanced age. This will result in a rise in the usage of HIFU systems in Spain's healthcare system for the radiation treatment of prostate cancer and pancreatic cancer, which is expected to increase the growth of Spain's high-intensity focused ultrasound systems market.
Hence, due to the above factors about high-intensity focused ultrasound systems, high-intensity ultrasound systems are expected to experience growth in the country.
Cardiology Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period
Cardiovascular diseases such as heart failure, cardiac murmur, ischemic heart disease, and acute pulmonary artery thromboembolism are diagnosed by ultrasound devices. The increasing prevalence of such diseases in Spain and the increasing geriatric population in the country are expected to boost segment growth. For instance, according to an article published by PubMed in September 2022, a study was conducted in Catalonia, Spain, which showed that there was a high prevalence of cardiovascular diseases in Spain, and it is associated with various risk factors such as diabetes, hypertension, hyperlipidemia, obesity, and smoking. Thus, the high prevalence of such chronic diseases in the country is expected to boost the growth of the studied market.
Moreover, a large geriatric population in the country is also expected to boost market growth, as cardiovascular diseases are often associated with older people, which is expected to increase the usage of ultrasound devices for disease diagnosis. For instance, according to the data updated by the United Nations Population Fund Dashboard in 2022, an estimated 21% of Spain's total population was 65 years or older in 2022.
Thus, the factors mentioned above, such as the high prevalence of cardiovascular diseases in Spain and the rising geriatric population, are expected to enhance segment growth.
